Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study von Bokemeyer, C., Bondarenko, I., Hartmann, J.T., de Braud, F., Schuch, G., Zubel, A., Celik, I., Schlichting, M., Koralewski, P.

Volltext

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study von Long, G.V., Flaherty, K.T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalà, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J.B.A.G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M.A., Lane, S.R., Legos, J.J., Mookerjee, B., Grob, J.-J.

Volltext

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population von Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., Thomas, M., de Braud, F.

Volltext

HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research von Pietrantonio, F., Caporale, M., Morano, F., Scartozzi, M., Gloghini, A., De Vita, F., Giommoni, E., Fornaro, L., Aprile, G., Melisi, D., Berenato, R., Mennitto, A., Volpi, C. C., Laterza, M. M., Pusceddu, V., Antonuzzo, L., Vasile, E., Ongaro, E., Simionato, F., de Braud, F., Torri, V., Di Bartolomeo, M.

Volltext

BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis von Cremolini, C., Di Bartolomeo, M., Amatu, A., Antoniotti, C., Moretto, R., Berenato, R., Perrone, F., Tamborini, E., Aprile, G., Lonardi, S., Sartore-Bianchi, A., Fontanini, G., Milione, M., Lauricella, C., Siena, S., Falcone, A., de Braud, F., Loupakis, F., Pietrantonio, F.

Volltext

Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer von Barault, L., Amatu, A., Bleeker, F.E., Moutinho, C., Falcomatà, C., Fiano, V., Cassingena, A., Siravegna, G., Milione, M., Cassoni, P., De Braud, F., Rudà, R., Soffietti, R., Venesio, T., Bardelli, A., Wesseling, P., de Witt Hamer, P., Pietrantonio, F., Siena, S., Esteller, M., Sartore-Bianchi, A., Di Nicolantonio, F.

Volltext

Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy von Fucà, G., Spagnoletti, A., Ambrosini, M., de Braud, F., Di Nicola, M.

Volltext

Toward the molecular dissection of peritoneal pseudomyxoma von Pietrantonio, F., Perrone, F., Mennitto, A., Gleeson, E.M., Milione, M., Tamborini, E., Busico, A., Settanni, G., Berenato, R., Caporale, M., Morano, F., Bossi, I., Pellegrinelli, A., Di Bartolomeo, M., de Braud, F., Baratti, D., Bowne, W.B., Kusamura, S., Deraco, M.

Volltext

Targeting the MET gene for the treatment of non-small-cell lung cancer von Gelsomino, F, Facchinetti, F, Haspinger, E.R, Garassino, M.C, Trusolino, L, De Braud, F, Tiseo, M

Volltext

Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes von Giannatempo, P., Greco, T., Mariani, L., Nicolai, N., Tana, S., Farè, E., Raggi, D., Piva, L., Catanzaro, M., Biasoni, D., Torelli, T., Stagni, S., Avuzzi, B., Maffezzini, M., Landoni, G., De Braud, F., Gianni, A.M., Sonpavde, G., Salvioni, R., Necchi, A.

Volltext

Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial von Biffi, R., Orsi, F., Pozzi, S., Pace, U., Bonomo, G., Monfardini, L., Della Vigna, P., Rotmensz, N., Radice, D., Zampino, M.G., Fazio, N., de Braud, F., Andreoni, B., Goldhirsch, A.

Volltext

Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA von La Rocca, E., De Santis, M. C., Silvestri, M., Ortolan, E., Valenti, M., Folli, S., de Braud, F. G., Bianchi, G. V., Scaperrotta, G. P., Apolone, G., Daidone, M. G., Cappelletti, V., Pruneri, G., Di Cosimo, S.

Volltext

Caring for patients with cancer in the COVID-19 era von van de Haar, Joris, Hoes, Louisa R., Coles, Charlotte E., Seamon, Kenneth, Fröhling, Stefan, Jäger, Dirk, Valenza, Franco, de Braud, Filippo, De Petris, Luigi, Bergh, Jonas, Ernberg, Ingemar, Besse, Benjamin, Barlesi, Fabrice, Garralda, Elena, Piris-Giménez, Alejandro, Baumann, Michael, Apolone, Giovanni, Soria, Jean Charles, Tabernero, Josep, Caldas, Carlos, Voest, Emile E.

Volltext

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study von Long, G.V., Flaherty, K.T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalá, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J.B.A.G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M.A., Lane, S.R., Legos, J.J., Mookerjee, B., Grob, J.-J.

Volltext

Mammographic density to predict response to neoadjuvant systemic breast cancer therapy von Di Cosimo, S., Depretto, C., Miceli, R., Baili, P., Ljevar, S., Sant, M., Cappelletti, V., Folli, S., Gennaro, M., De Braud, F. G., Bianchi, G., Vingiani, A., Pruneri, G., Marchianò, A., La Rocca, E., De Santis, M. C., Scaperrotta, G. P.

Volltext

The Long‐Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors von Mazzaferro, V., Sposito, C., Coppa, J., Miceli, R., Bhoori, S., Bongini, M., Camerini, T., Milione, M., Regalia, E., Spreafico, C., Gangeri, L., Buzzoni, R., Braud, F. G., De Feo, T., Mariani, L.

Volltext

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer von DE GRAMONT, A, FIGER, A, PAPAMICHAEL, D, LE BAIL, N, LOUVET, C, HENDLER, D, DE BRAUD, F, WILSON, C, MORVAN, F, BONETTI, A, SEYMOUR, M, HOMERIN, M, HMISSI, A, CASSIDY, J, BONI, C, CORTES-FUNES, H, CERVANTES, A, FREYER, G

Volltext

Innovative Therapy, Monoclonal Antibodies and Beyond von Di Nicola, M., Apetoh, L., Bellone, M., Colombo, M.P., Dotti, G., Ferrone, S., Muscolini, M., Hiscott, J., Anichini, A., Pupa, S.M., Braud, F.de, Del Vecchio, M.

Volltext

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels von COLLEONI, M, ROCCA, A, DE BRAUD, F, VIALE, G, GOLDHIRSCH, A, SANDRI, M. T, ZORZINO, L, MASCI, G, NOLE, F, PERUZZOTTI, G, ROBERTSON, C, ORLANDO, L, CINIERI, S

Volltext

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting von De Santis, F., Del Vecchio, M., Castagnoli, L., De Braud, F., Di Cosimo, S., Franceschini, D., Fucà, G., Hiscott, J., Malmberg, K.J., McGranahan, N., Pietrantonio, F., Rivoltini, L., Sangaletti, S., Tagliabue, E., Tripodo, C., Vernieri, C., Zitvogel, L., Pupa, S.M., Di Nicola, M.

Volltext